Skip to main content

Peer Review reports

From: RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy

Original Submission
15 Jan 2019 Submitted Original manuscript
8 Feb 2019 Reviewed Reviewer Report - Vincent Laudone
8 Feb 2019 Reviewed Reviewer Report - Ardalan Ahmad
15 Apr 2019 Author responded Author comments - Zhenxing Yang
Resubmission - Version 2
15 Apr 2019 Submitted Manuscript version 2
30 Apr 2019 Reviewed Reviewer Report - Ardalan Ahmad
8 May 2019 Reviewed Reviewer Report - Vincent Laudone
17 May 2019 Author responded Author comments - Zhenxing Yang
Resubmission - Version 3
17 May 2019 Submitted Manuscript version 3
26 May 2019 Reviewed Reviewer Report - Ardalan Ahmad
1 Jul 2019 Author responded Author comments - Zhenxing Yang
Resubmission - Version 4
1 Jul 2019 Submitted Manuscript version 4
3 Jul 2019 Author responded Author comments - Zhenxing Yang
Resubmission - Version 5
3 Jul 2019 Submitted Manuscript version 5
Publishing
8 Jul 2019 Editorially accepted
24 Jul 2019 Article published 10.1186/s12894-019-0497-x

You can find further information about peer review here.

Back to article page